Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 9.5B | 9.2B | 9.2B | 9.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 4.0B | 3.9B | 4.0B | 4.2B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.6B | 7.4B | 2.0B | 2.5B |
| Tax provision | 555.9M | 605.0M | 428.7M | 328.0M |
| Net income | 2.0B | 6.8B | 1.7B | 2.2B |
| Basic EPS | 1.9 | 6.3 | 1.6 | — |
| Diluted EPS | 1.9 | 6.3 | 1.6 | — |
| Basic average shares | 1.1B | 1.1B | 1.1B | — |
| Diluted average shares | 1.1B | 1.1B | 1.1B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 2.0B | 6.8B | 1.7B | 2.2B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |